Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Bio-Techne Corp (TECH : NSDQ)
 
 • Company Description   
Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits; and clinical diagnostic immunoassay kits. The Company also offers flow cytometry products; natural and synthetic chemical compounds; hematology controls and calibrators; and hematology control products. Bio-Techne Corporation, formerly known as Techne Corporation, is headquartered in Minneapolis, Minnesota.

Number of Employees: 3,100

 
 • Price / Volume Information   
Yesterday's Closing Price: $59.33 Daily Weekly Monthly
20 Day Moving Average: 2,441,164 shares
Shares Outstanding: 156.45 (millions)
Market Capitalization: $9,282.37 (millions)
Beta: 1.48
52 Week High: $72.16
52 Week Low: $46.01
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -16.88% -16.94%
12 Week -8.20% -9.12%
Year To Date 0.88% 0.36%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
614 MCKINLEY PLACE NE
-
MINNEAPOLIS,MN 55413
USA		 ph: 612-379-8854
fax: 612-656-4400		 ir@bio-techne.com http://www.bio-techne.com
 
 • General Corporate Information   
Officers
Kim Kelderman - President; Chief Executive Officer and Director
Robert V. Baumgartner - Chairman of the Board and Director
James Hippel - Chief Financial Officer
Julie Bushman - Director
Rupert Vessey - Director

Peer Information
Bio-Techne Corp (CORR.)
Bio-Techne Corp (RSPI)
Bio-Techne Corp (CGXP)
Bio-Techne Corp (BGEN)
Bio-Techne Corp (GTBP)
Bio-Techne Corp (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 09073M104
SIC: 2836
Fiscal Year
Fiscal Year End: June
Last Reported Quarter: 12/01/25
Next Expected EPS Date: 05/06/26
Share - Related Items
Shares Outstanding: 156.45
Most Recent Split Date: 11.00 (4.00:1)
Beta: 1.48
Market Capitalization: $9,282.37 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.54%
Current Fiscal Quarter EPS Consensus Estimate: $0.47 Indicated Annual Dividend: $0.32
Current Fiscal Year EPS Consensus Estimate: $1.71 Payout Ratio: 0.18
Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio: -0.01
Estmated Long-Term EPS Growth Rate: 8.81% Last Dividend Paid: 02/13/2026 - $0.16
Next EPS Report Date: 05/06/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 34.72
Trailing 12 Months: 33.71
PEG Ratio: 3.94
Price Ratios
Price/Book: 4.62
Price/Cash Flow: 24.27
Price / Sales: 7.64
EPS Growth
vs. Year Ago Period: 11.43%
vs. Previous Quarter: 8.33%
Sales Growth
vs. Year Ago Period: -0.39%
vs. Previous Quarter: 3.25%
ROE
12/31/25 - 13.94
09/30/25 - 13.59
06/30/25 - 13.43
ROA
12/31/25 - 10.76
09/30/25 - 10.43
06/30/25 - 10.32
Current Ratio
12/31/25 - 4.54
09/30/25 - 4.22
06/30/25 - 3.46
Quick Ratio
12/31/25 - 3.08
09/30/25 - 2.81
06/30/25 - 2.38
Operating Margin
12/31/25 - 22.68
09/30/25 - 22.29
06/30/25 - 22.44
Net Margin
12/31/25 - 6.67
09/30/25 - 6.41
06/30/25 - 6.02
Pre-Tax Margin
12/31/25 - 9.39
09/30/25 - 8.74
06/30/25 - 8.07
Book Value
12/31/25 - 12.85
09/30/25 - 12.62
06/30/25 - 12.24
Inventory Turnover
12/31/25 - 2.14
09/30/25 - 2.18
06/30/25 - 2.28
Debt-to-Equity
12/31/25 - 0.13
09/30/25 - 0.15
06/30/25 - 0.18
Debt-to-Capital
12/31/25 - 11.45
09/30/25 - 13.24
06/30/25 - 15.28
 

Powered by Zacks Investment Research ©